Amlodipine inhibits calcium ion influx across cell membranes selectively, with a greater effect on vascular smooth muscle cells than on cardiac muscle cells. Negative inotropic effects can be detected in vitro but such effects have not been seen in intact animals at therapeutic doses. Serum calcium concentration is not affected by amlodipine. Description: Amlodipine, a dihydropyridine Ca-channel blocker. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages. After oral administration of therapeutic doses of Amlodipine besylate tablets, absorption produces peak plasma concentrations between 6 and 12 hours. Absolute bioavailability has been estimated to be between 64 and 90%. The bioavailability of Amlodipine besylate tablets is not altered by the presence of food. Amlodipine is extensively (about 90%) converted to inactive metabolites via hepatic. In addition, the effects of amlodipine on BP and renal function were studied in hypertensive patients with renal impairment. In five of six nephrectomised salt-loaded SHR, increases in BP, urinary excretion of protein and serum creatinine were attenuated by the administration of 2 mg/kg/day of amlodipine. The progression of renal histological damage was also markedly decreased. The protective. Amlodipine inhibits calcium ion influx across cell membranes selectively, with a greater effect on vascular smooth muscle cells than on cardiac muscle cells. Negative inotropic effects can be detected in vitro but such effects have not been seen in intact animals at therapeutic doses. Serum calcium concentration is not affected by amlodipine. Concomitant use of amlodipine, a weak CYP3A4 inhibitor, and ergotamine, a CYP3A4 substrate with a narrow therapeutic range, may result in increased ergot alkaloid levels. Bendroflumethiazide; Nadolol: (Moderate) Coadministration of amlodipine and beta-blockers can reduce angina and improve exercise tolerance. Objective: To evaluate the appropriate dosing of amlodipine when converting patients from nifedipine extended-release (nifedipine ER) to amlodipine in the treatment of hypertension. Methods: Patients of the Outpatient Clinic of Cheyenne Veterans Affairs Medical Center, Wyoming, receiving nifedipine ER for the management of hypertension (systolic BP or SBP 140 mm Hg and diastolic BP or DBP. Evaluate for loss of therapeutic effect if medication must be coadministered. Adjust dose according to prescribing information if needed. chloramphenicol. chloramphenicol will increase the level or effect of amlodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. chloroquine. chloroquine will increase the level or effect of amlodipine by affecting. Amlodipine is a calcium channel blocker medication used to treat high blood pressure and coronary artery disease. Negative inotropic effects can be detected in vitro, but such effects have not been seen in intact animals at therapeutic doses. Among the two stereoisomers [R(+), S(–)], the (–) isomer has been reported to be more active than the (+) isomer. Serum calcium concentration is. Amlodipine besylate | C26H31ClN2O8S | CID 60496 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more. COVID-19 Information. Public health information (CDC) Research information (NIH) SARS-CoV-2 data (NCBI) Prevention and treatment information (HHS) Español.